Literature DB >> 33766016

Molecular characterization and antimicrobial resistance of potentially human-pathogenic Escherichia coli strains isolated from riding horses.

Pouya Reshadi1, Fatemeh Heydari1, Reza Ghanbarpour2, Mahboube Bagheri3, Maziar Jajarmi4, Mohadese Amiri5, Hesam Alizade6, Mahdi Askari Badouei7, Shademan Sahraei1, Nasrin Adib1.   

Abstract

BACKGROUND: Transmission of antimicrobial resistant and virulent Escherichia coli (E. coli) from animal to human has been considered as a public health concern. This study aimed to determine the phylogenetic background and prevalence of diarrheagenic E. coli and antimicrobial resistance in healthy riding-horses in Iran. In this research, the genes related to six main pathotypes of E. coli were screened. Also, genotypic and phenotypic antimicrobial resistance against commonly used antibiotics were studied, then phylo-grouping was performed on all the isolates.
RESULTS: Out of 65 analyzed isolates, 29.23 % (n = 19) were determined as STEC and 6.15 % (n = 4) as potential EPEC. The most prevalent antimicrobial resistance phenotypes were against amoxicillin/clavulanic acid (46.2 %) and ceftriaxone (38.5 %). blaTEM was the most detected resistance gene (98.4 %) among the isolates and 26.15 % of the E. coli isolates were determined as multi-drug resistant (MDR). Three phylo-types including B1 (76.92 %), A (13.85 %) and D (3.08 %) were detected among the isolates.
CONCLUSIONS: Due to the close interaction of horses and humans, these findings would place emphasis on the pathogenic and zoonotic potential of the equine strains and may help to design antimicrobial resistance stewardship programs to control the dissemination of virulent and multi-drug resistant E. coli strains in the community.

Entities:  

Keywords:  Antimicrobial resistance; Escherichia coli; Horse; Phylogeny; Virulence factors

Year:  2021        PMID: 33766016     DOI: 10.1186/s12917-021-02832-x

Source DB:  PubMed          Journal:  BMC Vet Res        ISSN: 1746-6148            Impact factor:   2.741


  6 in total

1.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

2.  [Occurrence of Salmonella spp. and shigatoxin-producing escherichia coli (STEC) in horse faeces and horse meat products].

Authors:  Rohtraud Pichner; Andrea Sander; Hartmut Steinrück; Manfred Gareis
Journal:  Berl Munch Tierarztl Wochenschr       Date:  2005 Jul-Aug       Impact factor: 0.328

3.  Multi-drug resistant Escherichia coli in diarrhoeagenic foals: Pulsotyping, phylotyping, serotyping, antibiotic resistance and virulence profiling.

Authors:  C A Kennedy; C Walsh; M Karczmarczyk; S O'Brien; N Akasheh; M Quirke; S Farrell-Ward; T Buckley; U Fogherty; K Kavanagh; C T Parker; T Sweeney; S Fanning
Journal:  Vet Microbiol       Date:  2018-08-07       Impact factor: 3.293

4.  Prevalence and genetic profiles of Shiga toxin-producing Escherichia coli strains isolated from buffaloes, cattle, and goats in central Vietnam.

Authors:  Hung Vu-Khac; Nancy A Cornick
Journal:  Vet Microbiol       Date:  2007-07-28       Impact factor: 3.293

5.  Prevalence of antimicrobial resistance from bacterial culture and susceptibility records from horse samples in South Africa.

Authors:  John K Chipangura; Thireshni Chetty; Marcia Kgoete; Vinny Naidoo
Journal:  Prev Vet Med       Date:  2017-10-12       Impact factor: 2.670

6.  Antimicrobial Usage in Horses: The Use of Electronic Data, Data Curation, and First Results.

Authors:  Anne Schnepf; Astrid Bienert-Zeit; Hatice Ertugrul; Rolf Wagels; Nicole Werner; Maria Hartmann; Karsten Feige; Lothar Kreienbrock
Journal:  Front Vet Sci       Date:  2020-04-29
  6 in total
  1 in total

1.  Molecular Characterization and Antimicrobial Resistance of Pathogenic Escherichia coli Strains in Children from Wolaita Sodo, Southern Ethiopia.

Authors:  Amanuel Wolde; Yosef Deneke; Tesfaye Sisay; Mesfin Mathewos
Journal:  J Trop Med       Date:  2022-07-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.